nodes	percent_of_prediction	percent_of_DWPC	metapath
Donepezil—HTR2A—coronary artery disease	0.114	1	CbGaD
Donepezil—Moexipril—Perindopril—coronary artery disease	0.107	0.266	CrCrCtD
Donepezil—Moexipril—Enalapril—coronary artery disease	0.0835	0.207	CrCrCtD
Donepezil—Moexipril—Trandolapril—coronary artery disease	0.0835	0.207	CrCrCtD
Donepezil—Moexipril—Lisinopril—coronary artery disease	0.0653	0.162	CrCrCtD
Donepezil—Moexipril—Ramipril—coronary artery disease	0.0633	0.157	CrCrCtD
Donepezil—CYP2C9—Fenofibrate—coronary artery disease	0.0192	0.0728	CbGbCtD
Donepezil—CYP2C9—Gemfibrozil—coronary artery disease	0.0153	0.0582	CbGbCtD
Donepezil—CYP2C9—Clopidogrel—coronary artery disease	0.0133	0.0504	CbGbCtD
Donepezil—CYP3A4—Ticagrelor—coronary artery disease	0.0125	0.0475	CbGbCtD
Donepezil—CYP2C9—Pitavastatin—coronary artery disease	0.0116	0.0441	CbGbCtD
Donepezil—CYP2C9—Valsartan—coronary artery disease	0.0113	0.0429	CbGbCtD
Donepezil—CYP3A4—Fenofibrate—coronary artery disease	0.0111	0.0423	CbGbCtD
Donepezil—CYP2D6—Niacin—coronary artery disease	0.0092	0.035	CbGbCtD
Donepezil—CYP3A4—Gemfibrozil—coronary artery disease	0.00891	0.0338	CbGbCtD
Donepezil—CYP2C9—Rosuvastatin—coronary artery disease	0.00856	0.0325	CbGbCtD
Donepezil—CYP2D6—Timolol—coronary artery disease	0.00856	0.0325	CbGbCtD
Donepezil—CYP2C9—Acetylsalicylic acid—coronary artery disease	0.00834	0.0317	CbGbCtD
Donepezil—CYP2C9—Simvastatin—coronary artery disease	0.00796	0.0302	CbGbCtD
Donepezil—CYP2C9—Pravastatin—coronary artery disease	0.00778	0.0296	CbGbCtD
Donepezil—CYP2C9—Lovastatin—coronary artery disease	0.00778	0.0296	CbGbCtD
Donepezil—CYP3A4—Clopidogrel—coronary artery disease	0.00772	0.0293	CbGbCtD
Donepezil—CYP2D6—Captopril—coronary artery disease	0.00753	0.0286	CbGbCtD
Donepezil—CYP2D6—Simvastatin—coronary artery disease	0.00727	0.0276	CbGbCtD
Donepezil—CYP3A4—Eplerenone—coronary artery disease	0.00718	0.0273	CbGbCtD
Donepezil—CYP2D6—Pravastatin—coronary artery disease	0.00712	0.027	CbGbCtD
Donepezil—CYP2D6—Lovastatin—coronary artery disease	0.00712	0.027	CbGbCtD
Donepezil—CYP2C9—Atorvastatin—coronary artery disease	0.00709	0.0269	CbGbCtD
Donepezil—CYP2C9—Losartan—coronary artery disease	0.00648	0.0246	CbGbCtD
Donepezil—CYP2D6—Atorvastatin—coronary artery disease	0.00648	0.0246	CbGbCtD
Donepezil—CYP3A4—Enalapril—coronary artery disease	0.0064	0.0243	CbGbCtD
Donepezil—CYP2C9—cardial valve—coronary artery disease	0.00514	0.23	CbGeAlD
Donepezil—CYP3A4—Ezetimibe—coronary artery disease	0.00498	0.0189	CbGbCtD
Donepezil—CYP3A4—Rosuvastatin—coronary artery disease	0.00498	0.0189	CbGbCtD
Donepezil—CYP3A4—Simvastatin—coronary artery disease	0.00463	0.0176	CbGbCtD
Donepezil—CYP3A4—Lovastatin—coronary artery disease	0.00453	0.0172	CbGbCtD
Donepezil—CYP3A4—Pravastatin—coronary artery disease	0.00453	0.0172	CbGbCtD
Donepezil—CYP3A4—Atorvastatin—coronary artery disease	0.00412	0.0157	CbGbCtD
Donepezil—CYP3A4—Losartan—coronary artery disease	0.00377	0.0143	CbGbCtD
Donepezil—HTR2A—arteriole—coronary artery disease	0.00262	0.117	CbGeAlD
Donepezil—Moexipril—ACE2—coronary artery disease	0.00172	0.734	CrCbGaD
Donepezil—HTR2A—pulmonary artery—coronary artery disease	0.00171	0.0768	CbGeAlD
Donepezil—HTR2A—sympathetic nervous system—coronary artery disease	0.00167	0.0747	CbGeAlD
Donepezil—HTR2A—vagus nerve—coronary artery disease	0.00161	0.0723	CbGeAlD
Donepezil—HTR2A—vein—coronary artery disease	0.00156	0.0699	CbGeAlD
Donepezil—HTR2A—autonomic nervous system—coronary artery disease	0.00112	0.0502	CbGeAlD
Donepezil—HRH3—blood—coronary artery disease	0.000903	0.0405	CbGeAlD
Donepezil—SIGMAR1—cardiac ventricle—coronary artery disease	0.000669	0.03	CbGeAlD
Donepezil—ACHE—heart—coronary artery disease	0.000655	0.0293	CbGeAlD
Donepezil—HTR2A—artery—coronary artery disease	0.000635	0.0285	CbGeAlD
Donepezil—SIGMAR1—myocardium—coronary artery disease	0.000629	0.0282	CbGeAlD
Donepezil—HTR2A—endothelium—coronary artery disease	0.000537	0.0241	CbGeAlD
Donepezil—SIGMAR1—heart—coronary artery disease	0.000439	0.0197	CbGeAlD
Donepezil—SIGMAR1—cardiac atrium—coronary artery disease	0.000376	0.0168	CbGeAlD
Donepezil—Moexipril—ACE—coronary artery disease	0.000363	0.155	CrCbGaD
Donepezil—SIGMAR1—blood—coronary artery disease	0.000328	0.0147	CbGeAlD
Donepezil—CYP2C9—heart—coronary artery disease	0.000284	0.0127	CbGeAlD
Donepezil—CYP2C9—cardiovascular system—coronary artery disease	0.000268	0.012	CbGeAlD
Donepezil—Doxazosin—CYP2C19—coronary artery disease	0.000258	0.11	CrCbGaD
Donepezil—HTR2A—heart—coronary artery disease	0.000234	0.0105	CbGeAlD
Donepezil—HTR2A—cardiovascular system—coronary artery disease	0.000221	0.00989	CbGeAlD
Donepezil—CYP2C9—blood—coronary artery disease	0.000212	0.0095	CbGeAlD
Donepezil—HTR2A—blood—coronary artery disease	0.000175	0.00783	CbGeAlD
Donepezil—CYP3A4—blood—coronary artery disease	0.000162	0.00724	CbGeAlD
Donepezil—CYP2D6—blood—coronary artery disease	0.000159	0.00713	CbGeAlD
Donepezil—Decreased appetite—Losartan—coronary artery disease	2.64e-05	0.000185	CcSEcCtD
Donepezil—Abdominal pain—Captopril—coronary artery disease	2.63e-05	0.000184	CcSEcCtD
Donepezil—Body temperature increased—Captopril—coronary artery disease	2.63e-05	0.000184	CcSEcCtD
Donepezil—Dizziness—Simvastatin—coronary artery disease	2.62e-05	0.000184	CcSEcCtD
Donepezil—Rash—Ezetimibe—coronary artery disease	2.62e-05	0.000184	CcSEcCtD
Donepezil—Dermatitis—Ezetimibe—coronary artery disease	2.62e-05	0.000184	CcSEcCtD
Donepezil—Confusional state—Ramipril—coronary artery disease	2.62e-05	0.000184	CcSEcCtD
Donepezil—Discomfort—Timolol—coronary artery disease	2.62e-05	0.000184	CcSEcCtD
Donepezil—Asthenia—Niacin—coronary artery disease	2.61e-05	0.000183	CcSEcCtD
Donepezil—Fatigue—Losartan—coronary artery disease	2.61e-05	0.000183	CcSEcCtD
Donepezil—Headache—Ezetimibe—coronary artery disease	2.61e-05	0.000183	CcSEcCtD
Donepezil—Malaise—Lisinopril—coronary artery disease	2.6e-05	0.000183	CcSEcCtD
Donepezil—Oedema—Ramipril—coronary artery disease	2.6e-05	0.000182	CcSEcCtD
Donepezil—Vertigo—Lisinopril—coronary artery disease	2.6e-05	0.000182	CcSEcCtD
Donepezil—Dry mouth—Timolol—coronary artery disease	2.59e-05	0.000182	CcSEcCtD
Donepezil—Constipation—Losartan—coronary artery disease	2.59e-05	0.000182	CcSEcCtD
Donepezil—Pain—Losartan—coronary artery disease	2.59e-05	0.000182	CcSEcCtD
Donepezil—Syncope—Lisinopril—coronary artery disease	2.59e-05	0.000182	CcSEcCtD
Donepezil—Vomiting—Eplerenone—coronary artery disease	2.59e-05	0.000181	CcSEcCtD
Donepezil—Feeling abnormal—Furosemide—coronary artery disease	2.59e-05	0.000181	CcSEcCtD
Donepezil—Nausea—Fenofibrate—coronary artery disease	2.58e-05	0.000181	CcSEcCtD
Donepezil—Pruritus—Niacin—coronary artery disease	2.58e-05	0.000181	CcSEcCtD
Donepezil—Asthenia—Pravastatin—coronary artery disease	2.57e-05	0.00018	CcSEcCtD
Donepezil—Gastrointestinal pain—Furosemide—coronary artery disease	2.57e-05	0.00018	CcSEcCtD
Donepezil—Rash—Eplerenone—coronary artery disease	2.57e-05	0.00018	CcSEcCtD
Donepezil—Urticaria—Perindopril—coronary artery disease	2.57e-05	0.00018	CcSEcCtD
Donepezil—Hypersensitivity—Trandolapril—coronary artery disease	2.57e-05	0.00018	CcSEcCtD
Donepezil—Dermatitis—Eplerenone—coronary artery disease	2.57e-05	0.00018	CcSEcCtD
Donepezil—Diarrhoea—Valsartan—coronary artery disease	2.56e-05	0.00018	CcSEcCtD
Donepezil—Confusional state—Timolol—coronary artery disease	2.56e-05	0.00018	CcSEcCtD
Donepezil—Shock—Ramipril—coronary artery disease	2.56e-05	0.000179	CcSEcCtD
Donepezil—Hypersensitivity—Enalapril—coronary artery disease	2.56e-05	0.000179	CcSEcCtD
Donepezil—Body temperature increased—Perindopril—coronary artery disease	2.56e-05	0.000179	CcSEcCtD
Donepezil—Abdominal pain—Perindopril—coronary artery disease	2.56e-05	0.000179	CcSEcCtD
Donepezil—Diarrhoea—Olmesartan—coronary artery disease	2.55e-05	0.000179	CcSEcCtD
Donepezil—Headache—Eplerenone—coronary artery disease	2.55e-05	0.000179	CcSEcCtD
Donepezil—Nervous system disorder—Ramipril—coronary artery disease	2.55e-05	0.000179	CcSEcCtD
Donepezil—Thrombocytopenia—Ramipril—coronary artery disease	2.55e-05	0.000178	CcSEcCtD
Donepezil—Oedema—Timolol—coronary artery disease	2.54e-05	0.000178	CcSEcCtD
Donepezil—Pruritus—Pravastatin—coronary artery disease	2.54e-05	0.000178	CcSEcCtD
Donepezil—Loss of consciousness—Lisinopril—coronary artery disease	2.54e-05	0.000178	CcSEcCtD
Donepezil—Nausea—Clopidogrel—coronary artery disease	2.54e-05	0.000178	CcSEcCtD
Donepezil—Infection—Timolol—coronary artery disease	2.52e-05	0.000177	CcSEcCtD
Donepezil—Vomiting—Simvastatin—coronary artery disease	2.52e-05	0.000177	CcSEcCtD
Donepezil—Hypersensitivity—Telmisartan—coronary artery disease	2.52e-05	0.000177	CcSEcCtD
Donepezil—Cough—Lisinopril—coronary artery disease	2.52e-05	0.000177	CcSEcCtD
Donepezil—Nausea—Lovastatin—coronary artery disease	2.52e-05	0.000177	CcSEcCtD
Donepezil—Hyperhidrosis—Ramipril—coronary artery disease	2.51e-05	0.000176	CcSEcCtD
Donepezil—Rash—Simvastatin—coronary artery disease	2.5e-05	0.000175	CcSEcCtD
Donepezil—Dermatitis—Simvastatin—coronary artery disease	2.5e-05	0.000175	CcSEcCtD
Donepezil—Asthenia—Trandolapril—coronary artery disease	2.5e-05	0.000175	CcSEcCtD
Donepezil—Shock—Timolol—coronary artery disease	2.5e-05	0.000175	CcSEcCtD
Donepezil—Feeling abnormal—Losartan—coronary artery disease	2.5e-05	0.000175	CcSEcCtD
Donepezil—Urticaria—Furosemide—coronary artery disease	2.5e-05	0.000175	CcSEcCtD
Donepezil—Diarrhoea—Niacin—coronary artery disease	2.49e-05	0.000175	CcSEcCtD
Donepezil—Nervous system disorder—Timolol—coronary artery disease	2.49e-05	0.000175	CcSEcCtD
Donepezil—Asthenia—Enalapril—coronary artery disease	2.49e-05	0.000174	CcSEcCtD
Donepezil—Headache—Simvastatin—coronary artery disease	2.49e-05	0.000174	CcSEcCtD
Donepezil—Abdominal pain—Furosemide—coronary artery disease	2.48e-05	0.000174	CcSEcCtD
Donepezil—Body temperature increased—Furosemide—coronary artery disease	2.48e-05	0.000174	CcSEcCtD
Donepezil—Gastrointestinal pain—Losartan—coronary artery disease	2.48e-05	0.000174	CcSEcCtD
Donepezil—Dizziness—Valsartan—coronary artery disease	2.48e-05	0.000174	CcSEcCtD
Donepezil—Anorexia—Ramipril—coronary artery disease	2.48e-05	0.000174	CcSEcCtD
Donepezil—Nausea—Ezetimibe—coronary artery disease	2.47e-05	0.000173	CcSEcCtD
Donepezil—Dizziness—Olmesartan—coronary artery disease	2.47e-05	0.000173	CcSEcCtD
Donepezil—Pruritus—Trandolapril—coronary artery disease	2.47e-05	0.000173	CcSEcCtD
Donepezil—Arthralgia—Lisinopril—coronary artery disease	2.46e-05	0.000172	CcSEcCtD
Donepezil—Chest pain—Lisinopril—coronary artery disease	2.46e-05	0.000172	CcSEcCtD
Donepezil—Myalgia—Lisinopril—coronary artery disease	2.46e-05	0.000172	CcSEcCtD
Donepezil—Hyperhidrosis—Timolol—coronary artery disease	2.46e-05	0.000172	CcSEcCtD
Donepezil—Asthenia—Telmisartan—coronary artery disease	2.46e-05	0.000172	CcSEcCtD
Donepezil—Pruritus—Enalapril—coronary artery disease	2.46e-05	0.000172	CcSEcCtD
Donepezil—Diarrhoea—Pravastatin—coronary artery disease	2.46e-05	0.000172	CcSEcCtD
Donepezil—Anxiety—Lisinopril—coronary artery disease	2.45e-05	0.000172	CcSEcCtD
Donepezil—Discomfort—Lisinopril—coronary artery disease	2.43e-05	0.00017	CcSEcCtD
Donepezil—Hypotension—Ramipril—coronary artery disease	2.43e-05	0.00017	CcSEcCtD
Donepezil—Anorexia—Timolol—coronary artery disease	2.42e-05	0.00017	CcSEcCtD
Donepezil—Pruritus—Telmisartan—coronary artery disease	2.42e-05	0.00017	CcSEcCtD
Donepezil—Nausea—Eplerenone—coronary artery disease	2.42e-05	0.00017	CcSEcCtD
Donepezil—Dizziness—Niacin—coronary artery disease	2.41e-05	0.000169	CcSEcCtD
Donepezil—Urticaria—Losartan—coronary artery disease	2.41e-05	0.000169	CcSEcCtD
Donepezil—Dry mouth—Lisinopril—coronary artery disease	2.41e-05	0.000169	CcSEcCtD
Donepezil—Abdominal pain—Losartan—coronary artery disease	2.4e-05	0.000168	CcSEcCtD
Donepezil—Body temperature increased—Losartan—coronary artery disease	2.4e-05	0.000168	CcSEcCtD
Donepezil—Asthenia—Captopril—coronary artery disease	2.39e-05	0.000167	CcSEcCtD
Donepezil—Diarrhoea—Trandolapril—coronary artery disease	2.38e-05	0.000167	CcSEcCtD
Donepezil—Vomiting—Valsartan—coronary artery disease	2.38e-05	0.000167	CcSEcCtD
Donepezil—Confusional state—Lisinopril—coronary artery disease	2.38e-05	0.000167	CcSEcCtD
Donepezil—Diarrhoea—Enalapril—coronary artery disease	2.37e-05	0.000166	CcSEcCtD
Donepezil—Hypotension—Timolol—coronary artery disease	2.37e-05	0.000166	CcSEcCtD
Donepezil—Dizziness—Pravastatin—coronary artery disease	2.37e-05	0.000166	CcSEcCtD
Donepezil—Vomiting—Olmesartan—coronary artery disease	2.37e-05	0.000166	CcSEcCtD
Donepezil—Musculoskeletal discomfort—Ramipril—coronary artery disease	2.37e-05	0.000166	CcSEcCtD
Donepezil—Rash—Valsartan—coronary artery disease	2.36e-05	0.000166	CcSEcCtD
Donepezil—Dermatitis—Valsartan—coronary artery disease	2.36e-05	0.000165	CcSEcCtD
Donepezil—Nausea—Simvastatin—coronary artery disease	2.36e-05	0.000165	CcSEcCtD
Donepezil—Oedema—Lisinopril—coronary artery disease	2.36e-05	0.000165	CcSEcCtD
Donepezil—Pruritus—Captopril—coronary artery disease	2.36e-05	0.000165	CcSEcCtD
Donepezil—Rash—Olmesartan—coronary artery disease	2.35e-05	0.000165	CcSEcCtD
Donepezil—Insomnia—Ramipril—coronary artery disease	2.35e-05	0.000165	CcSEcCtD
Donepezil—Dermatitis—Olmesartan—coronary artery disease	2.35e-05	0.000165	CcSEcCtD
Donepezil—Headache—Valsartan—coronary artery disease	2.35e-05	0.000165	CcSEcCtD
Donepezil—Diarrhoea—Telmisartan—coronary artery disease	2.34e-05	0.000164	CcSEcCtD
Donepezil—Infection—Lisinopril—coronary artery disease	2.34e-05	0.000164	CcSEcCtD
Donepezil—Headache—Olmesartan—coronary artery disease	2.34e-05	0.000164	CcSEcCtD
Donepezil—Paraesthesia—Ramipril—coronary artery disease	2.33e-05	0.000164	CcSEcCtD
Donepezil—Shock—Lisinopril—coronary artery disease	2.32e-05	0.000163	CcSEcCtD
Donepezil—Asthenia—Perindopril—coronary artery disease	2.32e-05	0.000162	CcSEcCtD
Donepezil—Dyspnoea—Ramipril—coronary artery disease	2.32e-05	0.000162	CcSEcCtD
Donepezil—Vomiting—Niacin—coronary artery disease	2.32e-05	0.000162	CcSEcCtD
Donepezil—Musculoskeletal discomfort—Timolol—coronary artery disease	2.32e-05	0.000162	CcSEcCtD
Donepezil—Hypersensitivity—Furosemide—coronary artery disease	2.31e-05	0.000162	CcSEcCtD
Donepezil—Somnolence—Ramipril—coronary artery disease	2.31e-05	0.000162	CcSEcCtD
Donepezil—Thrombocytopenia—Lisinopril—coronary artery disease	2.31e-05	0.000162	CcSEcCtD
Donepezil—Dizziness—Trandolapril—coronary artery disease	2.3e-05	0.000161	CcSEcCtD
Donepezil—Insomnia—Timolol—coronary artery disease	2.3e-05	0.000161	CcSEcCtD
Donepezil—Rash—Niacin—coronary artery disease	2.3e-05	0.000161	CcSEcCtD
Donepezil—Dermatitis—Niacin—coronary artery disease	2.3e-05	0.000161	CcSEcCtD
Donepezil—Dizziness—Enalapril—coronary artery disease	2.3e-05	0.000161	CcSEcCtD
Donepezil—Dyspepsia—Ramipril—coronary artery disease	2.29e-05	0.00016	CcSEcCtD
Donepezil—Pruritus—Perindopril—coronary artery disease	2.29e-05	0.00016	CcSEcCtD
Donepezil—Headache—Niacin—coronary artery disease	2.28e-05	0.00016	CcSEcCtD
Donepezil—Paraesthesia—Timolol—coronary artery disease	2.28e-05	0.00016	CcSEcCtD
Donepezil—Vomiting—Pravastatin—coronary artery disease	2.28e-05	0.00016	CcSEcCtD
Donepezil—Hyperhidrosis—Lisinopril—coronary artery disease	2.28e-05	0.00016	CcSEcCtD
Donepezil—Diarrhoea—Captopril—coronary artery disease	2.28e-05	0.00016	CcSEcCtD
Donepezil—Dyspnoea—Timolol—coronary artery disease	2.27e-05	0.000159	CcSEcCtD
Donepezil—Dizziness—Telmisartan—coronary artery disease	2.26e-05	0.000159	CcSEcCtD
Donepezil—Rash—Pravastatin—coronary artery disease	2.26e-05	0.000159	CcSEcCtD
Donepezil—Dermatitis—Pravastatin—coronary artery disease	2.26e-05	0.000158	CcSEcCtD
Donepezil—Decreased appetite—Ramipril—coronary artery disease	2.26e-05	0.000158	CcSEcCtD
Donepezil—Somnolence—Timolol—coronary artery disease	2.26e-05	0.000158	CcSEcCtD
Donepezil—Asthenia—Furosemide—coronary artery disease	2.25e-05	0.000158	CcSEcCtD
Donepezil—Headache—Pravastatin—coronary artery disease	2.25e-05	0.000158	CcSEcCtD
Donepezil—Anorexia—Lisinopril—coronary artery disease	2.25e-05	0.000157	CcSEcCtD
Donepezil—Gastrointestinal disorder—Ramipril—coronary artery disease	2.24e-05	0.000157	CcSEcCtD
Donepezil—Fatigue—Ramipril—coronary artery disease	2.24e-05	0.000157	CcSEcCtD
Donepezil—Dyspepsia—Timolol—coronary artery disease	2.24e-05	0.000157	CcSEcCtD
Donepezil—Hypersensitivity—Losartan—coronary artery disease	2.23e-05	0.000157	CcSEcCtD
Donepezil—Nausea—Valsartan—coronary artery disease	2.23e-05	0.000156	CcSEcCtD
Donepezil—Pruritus—Furosemide—coronary artery disease	2.22e-05	0.000156	CcSEcCtD
Donepezil—Constipation—Ramipril—coronary artery disease	2.22e-05	0.000156	CcSEcCtD
Donepezil—Nausea—Olmesartan—coronary artery disease	2.22e-05	0.000155	CcSEcCtD
Donepezil—Vomiting—Trandolapril—coronary artery disease	2.22e-05	0.000155	CcSEcCtD
Donepezil—Diarrhoea—Perindopril—coronary artery disease	2.21e-05	0.000155	CcSEcCtD
Donepezil—Decreased appetite—Timolol—coronary artery disease	2.21e-05	0.000155	CcSEcCtD
Donepezil—Vomiting—Enalapril—coronary artery disease	2.21e-05	0.000155	CcSEcCtD
Donepezil—Hypotension—Lisinopril—coronary artery disease	2.2e-05	0.000154	CcSEcCtD
Donepezil—Dizziness—Captopril—coronary artery disease	2.2e-05	0.000154	CcSEcCtD
Donepezil—Rash—Trandolapril—coronary artery disease	2.2e-05	0.000154	CcSEcCtD
Donepezil—Dermatitis—Trandolapril—coronary artery disease	2.2e-05	0.000154	CcSEcCtD
Donepezil—Gastrointestinal disorder—Timolol—coronary artery disease	2.19e-05	0.000154	CcSEcCtD
Donepezil—Fatigue—Timolol—coronary artery disease	2.19e-05	0.000154	CcSEcCtD
Donepezil—Rash—Enalapril—coronary artery disease	2.19e-05	0.000153	CcSEcCtD
Donepezil—Dermatitis—Enalapril—coronary artery disease	2.19e-05	0.000153	CcSEcCtD
Donepezil—Headache—Trandolapril—coronary artery disease	2.18e-05	0.000153	CcSEcCtD
Donepezil—Vomiting—Telmisartan—coronary artery disease	2.18e-05	0.000153	CcSEcCtD
Donepezil—Asthenia—Losartan—coronary artery disease	2.18e-05	0.000152	CcSEcCtD
Donepezil—Headache—Enalapril—coronary artery disease	2.17e-05	0.000152	CcSEcCtD
Donepezil—Pain—Timolol—coronary artery disease	2.17e-05	0.000152	CcSEcCtD
Donepezil—Nausea—Niacin—coronary artery disease	2.16e-05	0.000152	CcSEcCtD
Donepezil—Rash—Telmisartan—coronary artery disease	2.16e-05	0.000151	CcSEcCtD
Donepezil—Dermatitis—Telmisartan—coronary artery disease	2.16e-05	0.000151	CcSEcCtD
Donepezil—Diarrhoea—Furosemide—coronary artery disease	2.15e-05	0.000151	CcSEcCtD
Donepezil—Musculoskeletal discomfort—Lisinopril—coronary artery disease	2.15e-05	0.000151	CcSEcCtD
Donepezil—Pruritus—Losartan—coronary artery disease	2.14e-05	0.00015	CcSEcCtD
Donepezil—Headache—Telmisartan—coronary artery disease	2.14e-05	0.00015	CcSEcCtD
Donepezil—Feeling abnormal—Ramipril—coronary artery disease	2.14e-05	0.00015	CcSEcCtD
Donepezil—Dizziness—Perindopril—coronary artery disease	2.14e-05	0.00015	CcSEcCtD
Donepezil—Insomnia—Lisinopril—coronary artery disease	2.13e-05	0.000149	CcSEcCtD
Donepezil—Nausea—Pravastatin—coronary artery disease	2.13e-05	0.000149	CcSEcCtD
Donepezil—Gastrointestinal pain—Ramipril—coronary artery disease	2.13e-05	0.000149	CcSEcCtD
Donepezil—Paraesthesia—Lisinopril—coronary artery disease	2.12e-05	0.000148	CcSEcCtD
Donepezil—Vomiting—Captopril—coronary artery disease	2.12e-05	0.000148	CcSEcCtD
Donepezil—Dyspnoea—Lisinopril—coronary artery disease	2.1e-05	0.000147	CcSEcCtD
Donepezil—Rash—Captopril—coronary artery disease	2.1e-05	0.000147	CcSEcCtD
Donepezil—Dermatitis—Captopril—coronary artery disease	2.1e-05	0.000147	CcSEcCtD
Donepezil—Somnolence—Lisinopril—coronary artery disease	2.1e-05	0.000147	CcSEcCtD
Donepezil—Feeling abnormal—Timolol—coronary artery disease	2.09e-05	0.000147	CcSEcCtD
Donepezil—Headache—Captopril—coronary artery disease	2.09e-05	0.000146	CcSEcCtD
Donepezil—Gastrointestinal pain—Timolol—coronary artery disease	2.08e-05	0.000146	CcSEcCtD
Donepezil—Dizziness—Furosemide—coronary artery disease	2.08e-05	0.000146	CcSEcCtD
Donepezil—Dyspepsia—Lisinopril—coronary artery disease	2.08e-05	0.000145	CcSEcCtD
Donepezil—Diarrhoea—Losartan—coronary artery disease	2.07e-05	0.000145	CcSEcCtD
Donepezil—Nausea—Trandolapril—coronary artery disease	2.07e-05	0.000145	CcSEcCtD
Donepezil—Urticaria—Ramipril—coronary artery disease	2.07e-05	0.000145	CcSEcCtD
Donepezil—Nausea—Enalapril—coronary artery disease	2.06e-05	0.000144	CcSEcCtD
Donepezil—Vomiting—Perindopril—coronary artery disease	2.06e-05	0.000144	CcSEcCtD
Donepezil—Abdominal pain—Ramipril—coronary artery disease	2.05e-05	0.000144	CcSEcCtD
Donepezil—Body temperature increased—Ramipril—coronary artery disease	2.05e-05	0.000144	CcSEcCtD
Donepezil—Decreased appetite—Lisinopril—coronary artery disease	2.05e-05	0.000144	CcSEcCtD
Donepezil—Rash—Perindopril—coronary artery disease	2.04e-05	0.000143	CcSEcCtD
Donepezil—Dermatitis—Perindopril—coronary artery disease	2.04e-05	0.000143	CcSEcCtD
Donepezil—Gastrointestinal disorder—Lisinopril—coronary artery disease	2.04e-05	0.000143	CcSEcCtD
Donepezil—Nausea—Telmisartan—coronary artery disease	2.03e-05	0.000142	CcSEcCtD
Donepezil—Fatigue—Lisinopril—coronary artery disease	2.03e-05	0.000142	CcSEcCtD
Donepezil—Headache—Perindopril—coronary artery disease	2.02e-05	0.000142	CcSEcCtD
Donepezil—Urticaria—Timolol—coronary artery disease	2.02e-05	0.000141	CcSEcCtD
Donepezil—Constipation—Lisinopril—coronary artery disease	2.02e-05	0.000141	CcSEcCtD
Donepezil—Pain—Lisinopril—coronary artery disease	2.02e-05	0.000141	CcSEcCtD
Donepezil—Abdominal pain—Timolol—coronary artery disease	2.01e-05	0.000141	CcSEcCtD
Donepezil—Body temperature increased—Timolol—coronary artery disease	2.01e-05	0.000141	CcSEcCtD
Donepezil—Dizziness—Losartan—coronary artery disease	2e-05	0.00014	CcSEcCtD
Donepezil—Vomiting—Furosemide—coronary artery disease	2e-05	0.00014	CcSEcCtD
Donepezil—Rash—Furosemide—coronary artery disease	1.98e-05	0.000139	CcSEcCtD
Donepezil—Dermatitis—Furosemide—coronary artery disease	1.98e-05	0.000139	CcSEcCtD
Donepezil—Nausea—Captopril—coronary artery disease	1.98e-05	0.000139	CcSEcCtD
Donepezil—Headache—Furosemide—coronary artery disease	1.97e-05	0.000138	CcSEcCtD
Donepezil—Feeling abnormal—Lisinopril—coronary artery disease	1.94e-05	0.000136	CcSEcCtD
Donepezil—Gastrointestinal pain—Lisinopril—coronary artery disease	1.93e-05	0.000135	CcSEcCtD
Donepezil—Vomiting—Losartan—coronary artery disease	1.93e-05	0.000135	CcSEcCtD
Donepezil—Nausea—Perindopril—coronary artery disease	1.92e-05	0.000135	CcSEcCtD
Donepezil—Hypersensitivity—Ramipril—coronary artery disease	1.92e-05	0.000134	CcSEcCtD
Donepezil—Rash—Losartan—coronary artery disease	1.91e-05	0.000134	CcSEcCtD
Donepezil—Dermatitis—Losartan—coronary artery disease	1.91e-05	0.000134	CcSEcCtD
Donepezil—Headache—Losartan—coronary artery disease	1.9e-05	0.000133	CcSEcCtD
Donepezil—Urticaria—Lisinopril—coronary artery disease	1.87e-05	0.000131	CcSEcCtD
Donepezil—Hypersensitivity—Timolol—coronary artery disease	1.87e-05	0.000131	CcSEcCtD
Donepezil—Nausea—Furosemide—coronary artery disease	1.87e-05	0.000131	CcSEcCtD
Donepezil—Asthenia—Ramipril—coronary artery disease	1.87e-05	0.000131	CcSEcCtD
Donepezil—Abdominal pain—Lisinopril—coronary artery disease	1.86e-05	0.000131	CcSEcCtD
Donepezil—Body temperature increased—Lisinopril—coronary artery disease	1.86e-05	0.000131	CcSEcCtD
Donepezil—Pruritus—Ramipril—coronary artery disease	1.84e-05	0.000129	CcSEcCtD
Donepezil—Asthenia—Timolol—coronary artery disease	1.82e-05	0.000128	CcSEcCtD
Donepezil—Nausea—Losartan—coronary artery disease	1.8e-05	0.000126	CcSEcCtD
Donepezil—Pruritus—Timolol—coronary artery disease	1.8e-05	0.000126	CcSEcCtD
Donepezil—Diarrhoea—Ramipril—coronary artery disease	1.78e-05	0.000125	CcSEcCtD
Donepezil—Diarrhoea—Timolol—coronary artery disease	1.74e-05	0.000122	CcSEcCtD
Donepezil—Hypersensitivity—Lisinopril—coronary artery disease	1.74e-05	0.000122	CcSEcCtD
Donepezil—Dizziness—Ramipril—coronary artery disease	1.72e-05	0.00012	CcSEcCtD
Donepezil—Asthenia—Lisinopril—coronary artery disease	1.69e-05	0.000119	CcSEcCtD
Donepezil—Dizziness—Timolol—coronary artery disease	1.68e-05	0.000118	CcSEcCtD
Donepezil—Pruritus—Lisinopril—coronary artery disease	1.67e-05	0.000117	CcSEcCtD
Donepezil—Vomiting—Ramipril—coronary artery disease	1.65e-05	0.000116	CcSEcCtD
Donepezil—Rash—Ramipril—coronary artery disease	1.64e-05	0.000115	CcSEcCtD
Donepezil—Dermatitis—Ramipril—coronary artery disease	1.64e-05	0.000115	CcSEcCtD
Donepezil—Headache—Ramipril—coronary artery disease	1.63e-05	0.000114	CcSEcCtD
Donepezil—Vomiting—Timolol—coronary artery disease	1.62e-05	0.000113	CcSEcCtD
Donepezil—Diarrhoea—Lisinopril—coronary artery disease	1.61e-05	0.000113	CcSEcCtD
Donepezil—Rash—Timolol—coronary artery disease	1.6e-05	0.000112	CcSEcCtD
Donepezil—Dermatitis—Timolol—coronary artery disease	1.6e-05	0.000112	CcSEcCtD
Donepezil—Headache—Timolol—coronary artery disease	1.59e-05	0.000112	CcSEcCtD
Donepezil—Dizziness—Lisinopril—coronary artery disease	1.56e-05	0.000109	CcSEcCtD
Donepezil—Nausea—Ramipril—coronary artery disease	1.54e-05	0.000108	CcSEcCtD
Donepezil—Nausea—Timolol—coronary artery disease	1.51e-05	0.000106	CcSEcCtD
Donepezil—Vomiting—Lisinopril—coronary artery disease	1.5e-05	0.000105	CcSEcCtD
Donepezil—Rash—Lisinopril—coronary artery disease	1.49e-05	0.000104	CcSEcCtD
Donepezil—Dermatitis—Lisinopril—coronary artery disease	1.49e-05	0.000104	CcSEcCtD
Donepezil—Headache—Lisinopril—coronary artery disease	1.48e-05	0.000103	CcSEcCtD
Donepezil—Nausea—Lisinopril—coronary artery disease	1.4e-05	9.81e-05	CcSEcCtD
Donepezil—ACHE—Metabolism—PPARG—coronary artery disease	3.92e-06	7.45e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—AKR1B1—coronary artery disease	3.92e-06	7.45e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—HK2—coronary artery disease	3.92e-06	7.45e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—VCAN—coronary artery disease	3.91e-06	7.44e-05	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—TGFB1—coronary artery disease	3.89e-06	7.4e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—ALDOA—coronary artery disease	3.88e-06	7.39e-05	CbGpPWpGaD
Donepezil—ACHE—Metabolism—POMC—coronary artery disease	3.86e-06	7.35e-05	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—MAPK1—coronary artery disease	3.82e-06	7.26e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—ITGAV—coronary artery disease	3.81e-06	7.24e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—DCN—coronary artery disease	3.8e-06	7.23e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—KNG1—coronary artery disease	3.8e-06	7.22e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—POMC—coronary artery disease	3.78e-06	7.19e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—CREB1—coronary artery disease	3.78e-06	7.19e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—AGTR1—coronary artery disease	3.77e-06	7.18e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—DCN—coronary artery disease	3.77e-06	7.17e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—SLC27A1—coronary artery disease	3.75e-06	7.14e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—CCL2—coronary artery disease	3.7e-06	7.04e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—ALDH2—coronary artery disease	3.7e-06	7.04e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—IL6R—coronary artery disease	3.69e-06	7.02e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CXCL10—coronary artery disease	3.69e-06	7.01e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CPT1B—coronary artery disease	3.68e-06	7e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—LCAT—coronary artery disease	3.68e-06	7e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PLG—coronary artery disease	3.68e-06	6.99e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—ALDH2—coronary artery disease	3.67e-06	6.98e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—APOA4—coronary artery disease	3.61e-06	6.87e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—HBA1—coronary artery disease	3.61e-06	6.86e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CYP2C19—coronary artery disease	3.61e-06	6.86e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PIK3C2A—coronary artery disease	3.61e-06	6.86e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—LIPC—coronary artery disease	3.61e-06	6.86e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—APOC3—coronary artery disease	3.58e-06	6.81e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—ADRB2—coronary artery disease	3.58e-06	6.81e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	3.58e-06	6.8e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—LIPC—coronary artery disease	3.57e-06	6.8e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—HBA1—coronary artery disease	3.57e-06	6.8e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PIK3C2A—coronary artery disease	3.57e-06	6.8e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CYP2C19—coronary artery disease	3.57e-06	6.8e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—LDLR—coronary artery disease	3.56e-06	6.77e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—APOC3—coronary artery disease	3.55e-06	6.76e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PRKCE—coronary artery disease	3.53e-06	6.72e-05	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—JAK2—coronary artery disease	3.53e-06	6.71e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—LDLR—coronary artery disease	3.53e-06	6.71e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	3.53e-06	6.71e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—SOCS1—coronary artery disease	3.52e-06	6.7e-05	CbGpPWpGaD
Donepezil—ACHE—Metabolism—ALB—coronary artery disease	3.52e-06	6.7e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—SLC9A1—coronary artery disease	3.52e-06	6.69e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GSTT1—coronary artery disease	3.52e-06	6.69e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—S100B—coronary artery disease	3.52e-06	6.69e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PDHA1—coronary artery disease	3.49e-06	6.64e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GCLM—coronary artery disease	3.49e-06	6.64e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—SLC9A1—coronary artery disease	3.49e-06	6.63e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GSTT1—coronary artery disease	3.49e-06	6.63e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—SOCS3—coronary artery disease	3.48e-06	6.62e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CETP—coronary artery disease	3.48e-06	6.62e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GCLC—coronary artery disease	3.48e-06	6.62e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GCLC—coronary artery disease	3.45e-06	6.56e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CETP—coronary artery disease	3.45e-06	6.56e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—TGFBR2—coronary artery disease	3.44e-06	6.54e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—KITLG—coronary artery disease	3.44e-06	6.54e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—SDC1—coronary artery disease	3.44e-06	6.54e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—SDC1—coronary artery disease	3.41e-06	6.48e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—TXNRD1—coronary artery disease	3.38e-06	6.43e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CYP11B2—coronary artery disease	3.38e-06	6.43e-05	CbGpPWpGaD
Donepezil—ACHE—Metabolism—NOS3—coronary artery disease	3.37e-06	6.41e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—MMP3—coronary artery disease	3.36e-06	6.4e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—STAT5A—coronary artery disease	3.36e-06	6.4e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—SLC22A3—coronary artery disease	3.33e-06	6.33e-05	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—PIK3CA—coronary artery disease	3.31e-06	6.3e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—HADH—coronary artery disease	3.28e-06	6.24e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ARNTL—coronary artery disease	3.28e-06	6.24e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—APOB—coronary artery disease	3.25e-06	6.18e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PSMA6—coronary artery disease	3.25e-06	6.18e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PSMB5—coronary artery disease	3.25e-06	6.18e-05	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—CXCL8—coronary artery disease	3.22e-06	6.13e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PSMA6—coronary artery disease	3.22e-06	6.13e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PSMB5—coronary artery disease	3.22e-06	6.13e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	3.22e-06	6.11e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—JAK2—coronary artery disease	3.21e-06	6.1e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—EDN1—coronary artery disease	3.2e-06	6.08e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CTGF—coronary artery disease	3.17e-06	6.04e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CCL5—coronary artery disease	3.17e-06	6.04e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CTGF—coronary artery disease	3.15e-06	5.98e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—HMGCR—coronary artery disease	3.15e-06	5.98e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GOT2—coronary artery disease	3.15e-06	5.98e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CSF2—coronary artery disease	3.13e-06	5.95e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—FGF1—coronary artery disease	3.13e-06	5.95e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GOT2—coronary artery disease	3.12e-06	5.93e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—HMGCR—coronary artery disease	3.12e-06	5.93e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GPX2—coronary artery disease	3.11e-06	5.92e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	3.11e-06	5.92e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—APOA2—coronary artery disease	3.11e-06	5.92e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—LPL—coronary artery disease	3.1e-06	5.9e-05	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PTGS2—coronary artery disease	3.08e-06	5.86e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—RPS6KB1—coronary artery disease	3.08e-06	5.85e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—MEF2C—coronary artery disease	3.08e-06	5.85e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—SULT1A1—coronary artery disease	3.07e-06	5.84e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—HK1—coronary artery disease	3.07e-06	5.84e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GPX4—coronary artery disease	3.07e-06	5.84e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ABCG5—coronary artery disease	3.07e-06	5.84e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—HADHA—coronary artery disease	3.04e-06	5.77e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GSTA1—coronary artery disease	3e-06	5.71e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—ITGB3—coronary artery disease	3e-06	5.7e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—LPA—coronary artery disease	2.97e-06	5.64e-05	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—IL6—coronary artery disease	2.93e-06	5.58e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—CXCL8—coronary artery disease	2.93e-06	5.57e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PPP2CA—coronary artery disease	2.91e-06	5.54e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PLCB1—coronary artery disease	2.89e-06	5.5e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PLCB3—coronary artery disease	2.87e-06	5.47e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PLCB1—coronary artery disease	2.87e-06	5.45e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PRKCD—coronary artery disease	2.86e-06	5.44e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—APOA5—coronary artery disease	2.84e-06	5.41e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	2.81e-06	5.35e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—ABCA1—coronary artery disease	2.8e-06	5.33e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—C3—coronary artery disease	2.79e-06	5.31e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—P4HB—coronary artery disease	2.79e-06	5.31e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—ABCA1—coronary artery disease	2.78e-06	5.29e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	2.74e-06	5.21e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GGT1—coronary artery disease	2.72e-06	5.16e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GOT1—coronary artery disease	2.72e-06	5.16e-05	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—AKT1—coronary artery disease	2.71e-06	5.15e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GOT1—coronary artery disease	2.69e-06	5.12e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GGT1—coronary artery disease	2.69e-06	5.12e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—HIF1A—coronary artery disease	2.66e-06	5.07e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—AGT—coronary artery disease	2.65e-06	5.05e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—APOE—coronary artery disease	2.6e-06	4.95e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—LEP—coronary artery disease	2.6e-06	4.95e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—VCAN—coronary artery disease	2.58e-06	4.91e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—APOA1—coronary artery disease	2.57e-06	4.89e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ALDOA—coronary artery disease	2.56e-06	4.87e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—KDR—coronary artery disease	2.55e-06	4.85e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—MAPK14—coronary artery disease	2.53e-06	4.81e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—DCN—coronary artery disease	2.49e-06	4.73e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—ESR1—coronary artery disease	2.48e-06	4.72e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—F2—coronary artery disease	2.45e-06	4.67e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—FN1—coronary artery disease	2.45e-06	4.67e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—IL6ST—coronary artery disease	2.44e-06	4.65e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GSTP1—coronary artery disease	2.44e-06	4.64e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—NFKBIA—coronary artery disease	2.42e-06	4.61e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ALDH2—coronary artery disease	2.42e-06	4.6e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GSTP1—coronary artery disease	2.42e-06	4.6e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PPARGC1A—coronary artery disease	2.42e-06	4.6e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—HMOX1—coronary artery disease	2.41e-06	4.58e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PPARGC1A—coronary artery disease	2.4e-06	4.56e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—HMOX1—coronary artery disease	2.38e-06	4.54e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CAT—coronary artery disease	2.37e-06	4.51e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	2.36e-06	4.48e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—LIPC—coronary artery disease	2.36e-06	4.48e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CYP2C19—coronary artery disease	2.36e-06	4.48e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—HBA1—coronary artery disease	2.36e-06	4.48e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CAT—coronary artery disease	2.35e-06	4.48e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—KIT—coronary artery disease	2.35e-06	4.46e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—APOC3—coronary artery disease	2.34e-06	4.46e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—LDLR—coronary artery disease	2.33e-06	4.43e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—APOB—coronary artery disease	2.3e-06	4.38e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GSTT1—coronary artery disease	2.3e-06	4.38e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—SLC9A1—coronary artery disease	2.3e-06	4.38e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—APOB—coronary artery disease	2.28e-06	4.34e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GCLC—coronary artery disease	2.27e-06	4.33e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CETP—coronary artery disease	2.27e-06	4.33e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—GSK3B—coronary artery disease	2.25e-06	4.28e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—SDC1—coronary artery disease	2.25e-06	4.28e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GSTM1—coronary artery disease	2.24e-06	4.26e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—POMC—coronary artery disease	2.23e-06	4.25e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CREB1—coronary artery disease	2.23e-06	4.25e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GSTM1—coronary artery disease	2.22e-06	4.23e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—LPL—coronary artery disease	2.2e-06	4.18e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CCL2—coronary artery disease	2.19e-06	4.16e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—LPL—coronary artery disease	2.18e-06	4.15e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—IL6R—coronary artery disease	2.18e-06	4.15e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—IGF1—coronary artery disease	2.15e-06	4.09e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GPX1—coronary artery disease	2.15e-06	4.08e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—MAPK1—coronary artery disease	2.14e-06	4.07e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GPX1—coronary artery disease	2.13e-06	4.05e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PSMB5—coronary artery disease	2.12e-06	4.04e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PSMA6—coronary artery disease	2.12e-06	4.04e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CD36—coronary artery disease	2.09e-06	3.98e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CTGF—coronary artery disease	2.08e-06	3.95e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CD36—coronary artery disease	2.07e-06	3.94e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PPP2CA—coronary artery disease	2.06e-06	3.93e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—HMGCR—coronary artery disease	2.06e-06	3.91e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GOT2—coronary artery disease	2.06e-06	3.91e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PPP2CA—coronary artery disease	2.05e-06	3.89e-05	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—PIK3CA—coronary artery disease	2.04e-06	3.89e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—SERPINE1—coronary artery disease	2.04e-06	3.88e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—MTHFR—coronary artery disease	1.98e-06	3.77e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—FGF2—coronary artery disease	1.98e-06	3.76e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—MTHFR—coronary artery disease	1.96e-06	3.73e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—NOS3—coronary artery disease	1.95e-06	3.71e-05	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PIK3CA—coronary artery disease	1.9e-06	3.6e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—JAK2—coronary artery disease	1.89e-06	3.6e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PLCB1—coronary artery disease	1.89e-06	3.6e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—AGT—coronary artery disease	1.88e-06	3.58e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—AGT—coronary artery disease	1.87e-06	3.55e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—PIK3CA—coronary artery disease	1.86e-06	3.53e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—APOE—coronary artery disease	1.84e-06	3.51e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ABCA1—coronary artery disease	1.83e-06	3.49e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—APOE—coronary artery disease	1.83e-06	3.48e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—APOA1—coronary artery disease	1.82e-06	3.47e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—APOA1—coronary artery disease	1.81e-06	3.44e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GGT1—coronary artery disease	1.78e-06	3.38e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GOT1—coronary artery disease	1.78e-06	3.38e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.73e-06	3.29e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CXCL8—coronary artery disease	1.73e-06	3.29e-05	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—AKT1—coronary artery disease	1.67e-06	3.18e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CASP3—coronary artery disease	1.65e-06	3.15e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—IL6—coronary artery disease	1.64e-06	3.13e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CCND1—coronary artery disease	1.61e-06	3.06e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PPARG—coronary artery disease	1.61e-06	3.06e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GSTP1—coronary artery disease	1.59e-06	3.03e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PPARG—coronary artery disease	1.59e-06	3.03e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—POMC—coronary artery disease	1.58e-06	3.01e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	1.58e-06	3e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—HMOX1—coronary artery disease	1.57e-06	2.99e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—POMC—coronary artery disease	1.57e-06	2.99e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—MMP9—coronary artery disease	1.56e-06	2.97e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CAT—coronary artery disease	1.55e-06	2.95e-05	CbGpPWpGaD
Donepezil—ACHE—Metabolism—AKT1—coronary artery disease	1.55e-06	2.94e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—AKT1—coronary artery disease	1.52e-06	2.88e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—APOB—coronary artery disease	1.51e-06	2.87e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GSTM1—coronary artery disease	1.47e-06	2.79e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—ALB—coronary artery disease	1.44e-06	2.75e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—LPL—coronary artery disease	1.44e-06	2.74e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—ALB—coronary artery disease	1.43e-06	2.72e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—VEGFA—coronary artery disease	1.4e-06	2.67e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GPX1—coronary artery disease	1.4e-06	2.67e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—NOS3—coronary artery disease	1.38e-06	2.63e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—NOS3—coronary artery disease	1.37e-06	2.6e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CD36—coronary artery disease	1.37e-06	2.6e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PPP2CA—coronary artery disease	1.35e-06	2.57e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—MTHFR—coronary artery disease	1.3e-06	2.46e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—TGFB1—coronary artery disease	1.29e-06	2.45e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—MAPK1—coronary artery disease	1.26e-06	2.4e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PTGS2—coronary artery disease	1.26e-06	2.4e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PTGS2—coronary artery disease	1.25e-06	2.38e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—AGT—coronary artery disease	1.23e-06	2.34e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—APOE—coronary artery disease	1.21e-06	2.29e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—APOA1—coronary artery disease	1.19e-06	2.27e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PIK3CA—coronary artery disease	1.1e-06	2.09e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PPARG—coronary artery disease	1.05e-06	2e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—POMC—coronary artery disease	1.04e-06	1.97e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—IL6—coronary artery disease	9.71e-07	1.85e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ALB—coronary artery disease	9.44e-07	1.8e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—NOS3—coronary artery disease	9.03e-07	1.72e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—AKT1—coronary artery disease	8.96e-07	1.7e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PTGS2—coronary artery disease	8.26e-07	1.57e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PIK3CA—coronary artery disease	7.77e-07	1.48e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PIK3CA—coronary artery disease	7.71e-07	1.47e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—AKT1—coronary artery disease	6.35e-07	1.21e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—AKT1—coronary artery disease	6.3e-07	1.2e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PIK3CA—coronary artery disease	5.08e-07	9.67e-06	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—AKT1—coronary artery disease	4.15e-07	7.9e-06	CbGpPWpGaD
